Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma

Abstract

Noninvasive fetal RhD genotyping can be performed rapidly and reliably with the use of maternal plasma beginning in the second trimester of pregnancy.